Back to Search
PAUL DORINSKY, MD
MD
Pulmonary Disease Physician
NPI: 1710050539Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
PMID 11394729·Clin Ther·2001
4-observational
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
PMID 18951261·J Asthma·2008
2-rct
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
PMID 18328683·Respir Med·2008
4-observational
Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
PMID 18206361·Respir Med·2008
4-observational
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
PMID 17825690·Clin Ther·2007
4-observational
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
PMID 17030231·J Allergy Clin Immunol·2006
2-rct
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
PMID 16815137·J Allergy Clin Immunol·2006
2-rct
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
PMID 16647416·J Pediatr·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 OLD YORK RD
ABINGTON, PA 19001 - Phone
- (215) 481-2180
Quick Facts
- NPI
- 1710050539
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile